|
UBE2F expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.741250E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.124200E-02 |
| Normal-vs-Stage2 |
1.645980E-01 |
| Normal-vs-Stage3 |
1.733030E-01 |
| Normal-vs-Stage4 |
2.335800E-01 |
| Stage1-vs-Stage2 |
9.410400E-01 |
| Stage1-vs-Stage3 |
7.432800E-01 |
| Stage1-vs-Stage4 |
5.684000E-03 |
| Stage2-vs-Stage3 |
8.708600E-01 |
| Stage2-vs-Stage4 |
2.690200E-02 |
| Stage3-vs-Stage4 |
1.954150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.529600E-01 |
| Normal-vs-AfricanAmerican |
6.626500E-02 |
| Normal-vs-Asian |
1.910400E-01 |
| Caucasian-vs-AfricanAmerican |
2.841400E-01 |
| Caucasian-vs-Asian |
4.535000E-01 |
| AfricanAmerican-vs-Asian |
7.189400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.778580E-01 |
| Normal-vs-Female |
2.699600E-01 |
| Male-vs-Female |
8.594400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.677600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.308980E-01 |
| Normal-vs-Age(61-80Yrs) |
3.855200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.359400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.503600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.380400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.182000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.512200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.747400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.935600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.340400E-03 |
| Normal-vs-Grade 2 |
6.425600E-02 |
| Normal-vs-Grade 3 |
2.702400E-01 |
| Normal-vs-Grade 4 |
1.778600E-01 |
| Grade 1-vs-Grade 2 |
4.618200E-03 |
| Grade 1-vs-Grade 3 |
9.838000E-04 |
| Grade 1-vs-Grade 4 |
1.86643999999792E-05 |
| Grade 2-vs-Grade 3 |
2.689600E-01 |
| Grade 2-vs-Grade 4 |
4.402800E-03 |
| Grade 3-vs-Grade 4 |
2.656400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.643300E-03 |
| Normal-vs-ccB subtype |
8.291000E-01 |
| ccA subtype-vs-ccB subtype |
4.396400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.740200E-01 |
| Normal-vs-N1 |
2.152400E-01 |
| N0-vs-N1 |
1.361030E-01 |
|
|
